Candel Therapeutics, Inc. (CADL)
5.105
-0.84
(-14.20%)
USD |
NASDAQ |
Feb 20, 16:00
5.10
0.00 (0.00%)
After-Hours: 20:00
Candel Therapeutics EPS Diluted (Quarterly) : -0.2053 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.27M |
| Total Expenses (Quarterly) | 11.27M |
| Enterprise Value | 200.50M |
| Earnings Yield | -10.96% |
| Normalized Earnings Yield | -14.24 |